drugset / Trial / NCT01733758
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to examine the efficacy and safety of 2 dose levels of weekly subcutaneously injected albiglutide compared with placebo and an open label reference arm of daily subcutaneous injections of liraglutide, in Japanese subjects with Type 2 diabetes mellitus.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-06
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 0.9 mg | Subcutaneous |
| Subject | albiglutide | Peptide | 30 mg | Subcutaneous |
| Subject | albiglutide | Peptide | 50 mg | Subcutaneous |